Why did Tesla’s vehicle deliveries drop sharply?
How will Trump’s Vietnam trade deal impact tariffs?
What caused Del Monte Foods to file for bankruptcy?
Why is Microsoft laying off thousands in 2025?
How did U.S. lift chip software export curbs on China?
What’s driving the rise in bitcoin prices today?
Why is the GOP megabill facing House opposition?
Twice Yearly HIV Prevention Shot, Yeztugo, May Face Access Hurdles
forbes.com/sites/joshuacohen/2025/07/01/twice-yearly-hiv-prevention-shot-yeztugo-may-face-access-hurdles
Yeztugo is the first and only twice-yearly PrEP option to prevent HIV. It offers a more convenient option than a daily pill. But it may face insurance access challenges.
This story appeared on forbes.com, 2025-07-01 15:48:38.